Cosmos Health Inc (NQ: COSM )

0.6595 -0.0405 (-5.79%)
Streaming Delayed Price Updated: 9:58 AM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday. 
Via Benzinga
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning! 
Via InvestorPlace
A Look Into Cosmos Health's Debt
Shares of Cosmos Health Inc. (NASDAQ:COSM) decreased by 64.91% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase
Via ACCESSWIRE
Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements
Via ACCESSWIRE
Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market
Via ACCESSWIRE
Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million
Via ACCESSWIRE
Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta
Via ACCESSWIRE
Cosmos Health set to join Russell Microcap Index
Via ACCESSWIRE
Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M, or 70%, by the End of 2025 vs FY 2022.
Via ACCESSWIRE
Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income
Via ACCESSWIRE
Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement
Via ACCESSWIRE
Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders
Via ACCESSWIRE
Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022
Via ACCESSWIRE
Insiders Buying Simply Good Foods And 2 Other Stocks
Although US stocks closed mixed on Monday, there were a few notable insider trades. 
Via Benzinga
Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech
Via ACCESSWIRE
Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.
Via ACCESSWIRE
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
Via ACCESSWIRE
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories
Via ACCESSWIRE
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Via ACCESSWIRE
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests
Via ACCESSWIRE
BioMedNewsBreaks – Cosmos Health Inc. (NASDAQ: COSM) Begins Process for Upstream Dual Listing
Via Investor Brand Network
Cosmos Health Announces Application for Dual Listing on Upstream
Via ACCESSWIRE
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
Via ACCESSWIRE
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
Via ACCESSWIRE
Why Cosmos Health Shares Are Exploding Higher
Cosmos Health Inc (NASDAQ: COSM) shares are trading higher by 19.43% to $5.84 Tuesday afternoon after the company announced a $3 million share repurchase program. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.